P&G officer plans $27K stock sale Aug. 19

PROCTER & GAMBLE Co (PG) received a notice that officer Matthew W. Janzaruk intends to sell common stock under Rule 144.

Rhea-AI Filing Summary

PROCTER & GAMBLE Co (PG) received a notice that officer Matthew W. Janzaruk intends to sell common stock under Rule 144. The planned sale covers 189 shares of common stock, with an aggregate market value of $27,247.19, through Morgan Stanley Smith Barney on or about August 19, 2026 on the NYSE. The shares relate to a prior Performance Stock Program Award of 689 shares from The Procter & Gamble Company.

Key Figures

Shares to be sold: 189 shares Aggregate market value of shares to be sold: $27,247.19 Shares outstanding: 2,324,433,060 shares +4 more

7 metrics

Shares to be sold 189 shares Number of PG common shares covered by the planned Rule 144 sale

Aggregate market value of shares to be sold $27,247.19 Total market value of the 189 shares to be sold

Shares outstanding 2,324,433,060 shares PG common shares outstanding referenced in the notice

Shares acquired via Performance Stock Program Award 689 shares PG shares related to the Performance Stock Program Award

Approximate sale date 08/19/2026 Planned date for the Rule 144 sale of PG shares

Date of price basis 08/14/2026 Average of high and low PG price used for valuation

Date of notice 08/18/2026 Date the Rule 144 notice was filed

Key Terms

Rule 144, Performance Stock Program Award, attorney-in-fact, aggregate market value

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Performance Stock Program Award financial

"Performance Stock Program Award | The Procter & Gamble Company"

attorney-in-fact regulatory

"Signature | /s/ Wednesday Shipp, attorney-in-fact for Matthew W. Janzaruk"

An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

aggregate market value financial

"189 | 27247.19 | 2324433060 | 08/19/2026 | NYSE"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing mean for PROCTER & GAMBLE (PG)?

The filing states that an officer, Matthew W. Janzaruk, intends to sell 189 shares of PG common stock under Rule 144, a standard procedure for resales of restricted or control securities.

How many PROCTER & GAMBLE (PG) shares are planned to be sold under this Form 144?

The notice covers a proposed sale of 189 shares of PROCTER & GAMBLE common stock. The aggregate market value of these shares is listed as $27,247.19, based on pricing as of August 14, 2026.

Who is selling PROCTER & GAMBLE (PG) shares in this Form 144 filing?

The seller is Matthew W. Janzaruk, identified as an officer of PROCTER & GAMBLE. The filing is signed on his behalf by Wednesday Shipp as attorney-in-fact, indicating a delegated signing authority.

When will the PROCTER & GAMBLE (PG) shares be sold according to this Form 144?

The approximate sale date is August 19, 2026. The filing also notes that the valuation is based on the average of the high and low PG prices on August 14, 2026 for disclosure purposes.

What is the source of the PROCTER & GAMBLE (PG) shares being sold?

The 689 shares involved originated from a Performance Stock Program Award granted by The Procter & Gamble Company. Of these, 189 shares are covered by the current planned Rule 144 sale.

How many PROCTER & GAMBLE (PG) shares are outstanding as referenced in this Form 144?

The filing references 2,324,433,060 shares of PROCTER & GAMBLE common stock as outstanding. This figure provides context for the relatively small size of the 189-share proposed sale.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/18/2026 - 10:43 AM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001910008
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	PROCTER & GAMBLE Co
SEC File Number	001-00434
Address of Issuer	ONE PROCTER & GAMBLE PLAZA CINCINNATI OHIO 45202
Phone	5139831100
Name of Person for Whose Account the Securities are To Be Sold	Janzaruk Matthew W.
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 38th Floor New York NY 10004	189	27247.19	2324433060	08/19/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	08/19/2026	Performance Stock Program Award	The Procter & Gamble Company			689	08/19/2026	NA

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	Based on average of high and low price on August 14, 2026.
Date of Notice	08/18/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Wednesday Shipp, attorney-in-fact for Matthew W. Janzaruk
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)